Solid Biosciences Inc. (52)

Browse by Contract Category

Contracts

Consulting Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Erin Powers Brennan (Filed With SEC on September 30, 2022)
Registration Rights Agreement, dated September 29, 2022, by and among Solid Biosciences Inc. and the persons party thereto (Filed With SEC on September 30, 2022)
Form of Parent Support Agreement (Filed With SEC on September 30, 2022)
Agreement and Plan of Merger, dated as of September 29, 2022, by and among Solid Biosciences Inc., Greenland Merger Sub LLC, AavantiBio, Inc. and, solely in his capacity as the... (Filed With SEC on September 30, 2022)
Amendment No. 1 to Sublease, dated as of December 3, 2021, by and between Solid Biosciences, LLC and Twitter, Inc (Filed With SEC on March 14, 2022)
First Amendment, dated as of January 27, 2021, to the Exclusive Patent License by and between the Company and the Curators of the University of Missouri (Filed With SEC on March 15, 2021)
Collaboration and License Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on November 5, 2020)
Executive Transition and Separation Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Erin Powers Brennan (Filed With SEC on September 30, 2022)
Consulting Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Ilan Ganot (Filed With SEC on September 30, 2022)
Executive Transition and Separation Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Ilan Ganot (Filed With SEC on September 30, 2022)
Employment Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Alexander Cumbo (Filed With SEC on September 30, 2022)
Securities Purchase Agreement, dated September 29, 2022, by and among Solid Biosciences Inc. and the persons party thereto (Filed With SEC on September 30, 2022)
Form of Support and Joinder Agreement (Filed With SEC on September 30, 2022)
Summary of Non-Employee Director Compensation Policy (Filed With SEC on August 11, 2022)
Summary of Non-Employee Director Compensation Program (Filed With SEC on March 14, 2022)
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Joel Schneider (Filed With SEC on March 14, 2022)
Employment Agreement, dated as of March 1, 2021, by and between Solid Biosciences Inc. and Erin Powers Brennan (Filed With SEC on March 14, 2022)
Executive Chair Agreement, effective January 1, 2022, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on March 14, 2022)
2020 Equity Incentive Plan, as amended by Amendment No. 1 to 2020 Stock Incentive Plan (Filed With SEC on March 14, 2022)
Form of Restricted Stock Unit Agreement under the 2020 Equity Incentive Plan (Filed With SEC on March 14, 2022)
Form of Nonstatutory Inducement Stock Option Agreement (Filed With SEC on August 16, 2021)
Lease, dated June 15, 2021, between Solid Biosciences, Inc. and Hood Park LLC (Filed With SEC on August 16, 2021)
Consulting Agreement, dated as of January 4, 2021, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on May 14, 2021)
Underwriting Agreement, dated March 18, 2021, by and among the Company and Jefferies LLC, SVB Leerink LLC and Piper Sandler & Co (Filed With SEC on March 19, 2021)
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Jennifer Ziolkowski (Filed With SEC on March 15, 2021)
Consulting Agreement, dated as of November 19, 2020, by and between Solid Biosciences Inc. and Danforth Advisors, LLC (Filed With SEC on March 15, 2021)
Registration Rights Agreement, dated December 10, 2020, by and among the Company and the other parties thereto (Filed With SEC on December 11, 2020)
Securities Purchase Agreement, dated December 10, 2020, by and among the Company and the other parties thereto (Filed With SEC on December 11, 2020)
First Amendment, dated as of October 9, 2020, to the Exclusive Patent License by and between the Company and the University of Washington (Filed With SEC on November 5, 2020)
Investor Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on November 5, 2020)
Stock Purchase Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on November 5, 2020)
Form of Restricted Stock Unit Agreement under the 2020 Equity Incentive Plan (Filed With SEC on August 6, 2020)
Form of Stock Option Agreement under the 2020 Equity Incentive Plan (Filed With SEC on August 6, 2020)
Consulting Agreement, dated as of June 16, 2020, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on August 6, 2020)
Summary of Non-Employee Director Compensation Program (Filed With SEC on August 6, 2020)
Summary of Non-Employee Director Compensation Program (Filed With SEC on May 7, 2020)
Consulting Agreement, dated as of February 1, 2020, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on May 7, 2020)
Description of the Companys Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 12, 2020)
Consulting Agreement, dated as of January 1, 2020, by and between Solid Biosciences Inc. and Andrey Zarur (Filed With SEC on March 12, 2020)
Consulting Agreement, dated as of January 15, 2020 by and between Solid Biosciences Inc. and Jorge Quiroz (Filed With SEC on March 12, 2020)
Consulting Agreement, dated as of January 15, 2020, by and between Solid Biosciences Inc. and Alvaro Amorrortu (Filed With SEC on March 12, 2020)
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Jorge Quiroz (Filed With SEC on March 12, 2020)
Registration Rights Agreement, dated July 25, 2019, by and among the Company and the other parties thereto (Filed With SEC on July 26, 2019)
Form of Pre-Funded Warrant to Purchase Common Stock to be issued pursuant to the Securities Purchase Agreement (Filed With SEC on July 26, 2019)
Securities Purchase Agreement, dated July 25, 2019, by and among the Company and the other parties thereto (Filed With SEC on July 26, 2019)
Consulting Agreement, dated as of January 1, 2019, by and between Solid Biosciences Inc. and Andrey Zarur (Filed With SEC on May 13, 2019)
Form of Incentive Stock Option Agreement under 2018 Omnibus Incentive Plan (Filed With SEC on March 13, 2019)
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Carl Morris. Ph.D (Filed With SEC on March 13, 2019)
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Alvaro Amorrortu (Filed With SEC on March 13, 2019)
Form of Nonqualified Stock Option Agreement under 2018 Omnibus Incentive Plan (Filed With SEC on March 13, 2019)
Summary of Non-Employee Director Compensation Program (Filed With SEC on March 13, 2019)
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Ilan Ganot (Filed With SEC on March 13, 2019)